Updated:
MED-FINE Capital
Med-Fine Capital is an investment firm focused on healthcare and life sciences sectors. It manages RMB and USD funds, investing in early-stage biotechnology,...
MED-FINE Capital
Med-Fine Capital is an investment firm focused on healthcare and life sciences sectors. It manages RMB and USD funds, investing in early-stage biotechnology, medical devices, diagnostics, digital health, and healthcare services. Founded in 2014 in Shanghai, Med-Fine Capital has made 83 investments, including a Series C - II investment in Arthrone on April 03, 2026.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does MED-FINE Capital target?
The firm states it targets early-stage, seed, start-up, expansion, late-stage, and growth opportunities, all within healthcare and life sciences. This spans incubation-stage biotech platforms through to companies nearing commercialization.
Which sectors does MED-FINE Capital explicitly cover?
MED-FINE Capital is exclusively focused on healthcare and life sciences. Its website and public materials reference pharmaceutical, biotech, medical device, and healthcare service investments across China.
Where is MED-FINE Capital headquartered, and what is its geographic coverage?
The firm is headquartered in Shanghai, China, and its investment activities are stated to cover the broader China market. No additional international offices are publicly listed.
Who founded and leads MED-FINE Capital?
Specific principals are not named on the firm's public website or in widely available English-language sources. The firm describes its management team as having extensive pharmaceutical industry and venture capital experience.
Does MED-FINE Capital disclose its assets under management or fund sizes?
No. MED-FINE Capital has not publicly disclosed assets under management, aggregate deployment figures, or fund-level capitalizations in its currently available online materials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: